U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
RECOMBINANT HUMAN LECITHIN:CHOLESTEROL ACYLTRANSFERASE
XBA7E67HMJ
Investigational
General
Names
9
Classification
2
Identifiers
4
Subunits
1
Related Substances
1
RECOMBINANT HUMAN LECITHIN:CHOLESTEROL ACYLTRANSFERASE
XBA7E67HMJ
Investigational
General
Approval Year
Unknown
149,124
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
RECOMBINANT HUMAN LECITHIN:CHOLESTEROL ACYLTRANSFERASE
Common Name
English
ACP-501
Preferred Name
English
MEDI 6012 [WHO-DD]
Code
English
RECOMBINANT HUMAN LCAT
Common Name
English
MEDI-6012
Code
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of familial lecithin-cholesterol acyltransferase deficiency (FLD).
FDA ORPHAN DRUG
314010
Positive
EU ORPHAN DRUG
Positive
Treatment of lecithin-cholesterol-acyltransferase deficiency
EU-Orphan Drug
EU/3/12/1051
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
4
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
DRUG BANK
DB14833
PRIMARY
SMS_ID
100000183778
PRIMARY
FDA UNII
XBA7E67HMJ
PRIMARY
UNIPROT
P04180
PRIMARY
Showing 1 to 4 of 4 entries
Previous
1
Next
Subunits
1
Subunit 0
>SUBUNIT_0
Related Substances
1
ACTIVE MOIETY
XBA7E67HMJ
RECOMBINANT HUMAN LECITHIN:CHOLESTEROL ACYLTRANSFERASE
